PTDJX Fees and Costs — Principal LifeTime 2040 Fund, Class J

Data updated: 2026-09-25

The net expense ratio is 0.72%. This share class carries a deferred sales charge of up to 1.00%. Portfolio turnover was 39%.

PTDJX Fees and Expenses

Annual operating expenses and sales charges of PTDJX. Prospectus, as of March 1, 2026.

Annual operating expenses
Management fee0.00%
12b-1 fee0.15%
Other expenses0.03%
Gross expense ratio0.72%
Fee waiver—
Net expense ratio0.72%
Sales charges
Max front load0.00%
Max deferred load1.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

PTDJX Costs Over Time

On $10,000 invested in PTDJX, assuming 5% a year before costs, total costs come to $453 over 5 years, cutting the return by 0.76% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Sales charges$104$0$0
Fund expenses (net expense ratio 0.72%)$76$237$411
Lost growth on money paid in costs$0$12$41
Total costs$180$248$453
Value after costs$10,320$11,328$12,310
Impact on return, per year1.80%0.76%0.76%

PTDJX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $4.0B
  • Portfolio turnover (prospectus): 39%
  • Securities lending: none during the year

Principal LifeTime 2040 Fund Share Classes

Net expense ratio and maximum front-end load of each share class, cheapest first.

TickerClassNet expense ratioFront load
PTDIXInstitutional Class0.55%none
PTDJXClass J0.72%none
PTDPXClass R-50.80%none
PTDAXClass A0.88%5.50%
PTDMXClass R-31.11%none

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.